XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
OPERATING ACTIVITIES        
Net income $ 622.0 $ 520.9 $ 1,987.5 $ 1,742.9
Adjustments to reconcile net earnings to net cash provided from operating activities:        
Depreciation, amortization and depletion 212.5 192.0 625.4 597.6
Equity earnings of affiliate, net of dividends received 0.1 0.1 10.7 (0.3)
(Gain) loss on foreign currency transaction effect (7.4) 0.2 3.7 52.0
(Benefit) provision for deferred income taxes (49.6) 52.6 (43.3) 84.5
Other, net 7.2 8.1 21.7 25.5
Change in operating assets and liabilities:        
(Increase) / decrease in accounts receivable (63.1) (1.2) 263.1 292.9
(Increase) / decrease in inventories (2.4) 30.9 13.2 (57.9)
Increase / (decrease) in accounts payable and accrued liabilities 226.5 (24.9) 53.8 (768.6)
Decrease / (increase) in other operating assets and liabilities 104.0 (188.6) 96.3 (248.0)
Net cash provided by operating activities 1,049.8 590.1 3,032.1 1,720.6
INVESTING ACTIVITIES        
Capital expenditures (262.7) (227.9) (753.2) (657.6)
(Purchase) / proceeds from sale of short-term investments, net (246.8) 242.3 (38.8) 486.6
Other 0.5   0.6  
Net cash (used in) provided by investing activities (509.0) 14.4 (791.4) (171.0)
FINANCING ACTIVITIES        
Cash dividends paid to common stockholders (773.1) (579.8) (2,319.3) (2,319.3)
Other, net (2.0) (0.3) (6.4) (4.0)
Net cash (used in) financing activities (775.1) (580.1) (2,325.7) (2,323.3)
Effect of exchange rate changes on cash and cash equivalents 2.4 47.0 (17.6) (43.8)
(Decrease) / increase in cash and cash equivalents (231.9) 71.4 (102.6) (817.5)
Cash and cash equivalents, at beginning of period 2,199.0 2,113.1 2,069.7 3,002.0
Cash and cash equivalents, at end of period $ 1,967.1 $ 2,184.5 $ 1,967.1 $ 2,184.5